Background
==========

Previous studies indicate a role of P2X~7~ receptors in processes that lead to neuronal death. The main objective of our study was to examine whether genetic deletion or pharmacological blockade of P2X~7~ receptors influenced dopaminergic cell death in various models of Parkinson's disease (PD).

Methods
=======

PC12 cells and primary mesencephalic neurons were used in culture, and the striatum and the substantia nigra were prepared from wild-type and P2X~7~ receptor knockout mice. Rotenone and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) treatments were applied *in vitro* and *in vivo* to reproduce neurochemical hallmarks of PD. Receptor expression, cell survival indicators, and endogenous biogenic amine, amino acid, adenine nucleotide and endocannabinoid contents were analyzed.

Results
=======

mRNA encoding P2X~7~ and P2X~4~ receptors was up-regulated after treatment of PC12 cells with MPTP. P2X~7~ antagonists protected against MPTP- and rotenone-induced toxicity in the LDH assay, but failed to protect after rotenone treatment in the MTT assay in PC12 cells and in primary midbrain culture. *In vivo* MPTP and *in vitro* rotenone pretreatments increased the mRNA expression of P2X~7~ receptors in the striatum and substantia nigra of wild-type mice. Basal mRNA expression of P2X~4~ receptors was higher in P2X~7~ knockout mice and was further up-regulated by MPTP treatment. Genetic deletion or pharmacological inhibition of P2X~7~ receptors did not change survival rate or depletion of striatal endogenous dopamine (DA) content after *in vivo* MPTP or *in vitro* rotenone treatment. However, depletion of norepinephrine was significant after MPTP treatment only in P2X~7~ knockout mice. The basal ATP content was higher in the substantia nigra of wild-type mice, but the ADP level was lower. Rotenone treatment elicited a similar reduction in ATP content in the substantia nigra of both genotypes, whereas reduction of ATP was more pronounced after rotenone treatment in striatal slices of P2X~7~-deficient mice. Although the endogenous amino acid content remained unchanged, the level of the endocannabinoid, 2-arachidonoyl glycerol (2-AG), was elevated by rotenone in the striatum of wild-type mice, an effect that was absent in mice deficient in P2X~7~ receptors.

Conclusions
===========

We conclude that P2X~7~ receptor deficiency or inhibition does not support the survival of dopaminergic neurons in *in vivo* or *in vitro* models of PD.
